Why Mozart? Dartmouth researchers seek mechanisms for the anti-epileptic properties of Mozart’s K448 as a therapeutic potential for epilepsy.
Researchers in the laboratory of Mary Jo Turk, PhD, Co-Director of the Immunology and Cancer Immunotherapy Research Program at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center have spent the past year studying immunity to metastatic cancer within lymph nodes.
Researchers at Dartmouth’s Geisel School of Medicine have received a $12.5 million renewal grant from the National Institutes of Health to continue the groundbreaking work of the Institute for Biomolecular Targeting at Dartmouth.
Now entering its second year, the Dartmouth Innovations Accelerator for Cancer has attracted more than $3.5 million in philanthropy and has helped 17 research teams advance their work. In this video researchers from the winning teams describe how the Accelerator is advancing their innovations.
Developed at Geisel, ScanGEO make mining publicly available gene expression data a snap.
The Geisel School of Medicine at Dartmouth’s Center for Technology and Behavioral Health (CTBH) has received a five-year renewal grant of more than $7.1 million from The National Institute on Drug Abuse (NIDA).
Geisel’s Munck-Pfefferkorn Grant Awards support faculty investigators launching new and innovative research projects.
A team of researchers at Dartmouth’s Geisel School of Medicine, led by Glyn Elwyn, MD, PhD, MSc, and Marie-Anne Durand, PhD, has received a $6.2 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to test approaches that may increase confidence in the COVID-19 vaccine among those working in long-term care facilities.
A new Dartmouth-led study published this month in the New England Journal of Medicine sheds light on the role U.S. health systems play concerning racial inequality in prescription pain medicine receipt.
Dr. Eugene Nelson discusses how research teams from The Dartmouth Institute for Health Policy and Clinical Practice, East Carolina University’s Brody School of Medicine, and Dartmouth-Hitchcock Health are partnering to address the negative impacts of the current pandemic as well as those that may occur in the future.